
INSP Stock Forecast & Price Target
INSP Analyst Ratings
Bulls say
Inspire Medical Systems is experiencing growth and success due to its dominant position in the minimally invasive solutions market for patients with obstructive sleep apnea (OSA). With a strong presence in the United States and other countries, the company generates the majority of its revenue from its flagship product, the Inspire system. While there are potential risks such as changes in reimbursement/coding and competition from other neurostimulation products, the company's overall growth prospects and forecasted earnings demonstrate its potential for continued success.
Bears say
Inspire Medical Systems is facing several headwinds that could potentially impact its financial performance. These headwinds include lower reimbursement rates for its Inspire system procedures, uncertainty around coding and pricing of its products, potential competition from other devices and therapies, and delays in obtaining a new CPT code that could support reimbursement for its newer device, the Genio implant. These factors could lead to lower revenue growth and margin compression for the company in the near term, and it may struggle to achieve double-digit revenue growth without addressing these challenges in a timely manner. Overall, we believe that the uncertainties surrounding reimbursement and coding for the company's products make its stock a risky investment at this time, and we have a negative outlook on its future financial performance.
This aggregate rating is based on analysts' research of Inspire Medical Systems Inc and is not a guaranteed prediction by Public.com or investment advice.
INSP Analyst Forecast & Price Prediction
Start investing in INSP
Order type
Buy in
Order amount
Est. shares
0 shares